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Abstract
Background: In a previous feasibility study (APROPOS) in a single municipality of the Netherlands, we showed that
a locally tailored preconception care (PCC) approach has the potential to positively affect preconceptional lifestyle
behaviours. Therefore, we designed a second study (APROPOS-II) to obtain a more robust body of evidence: a
larger group of respondents, more municipalities, randomization, and a more comprehensive set of (clinical)
outcomes. The aim of this study is to assess the effectiveness and the implementation process of a local PCC-
approach on preconceptional lifestyle behaviours, health outcomes and the reach of PCC among prospective
parents and healthcare providers.
Methods: This study is an effectiveness-implementation hybrid type 2 trial. This involves a stepped-wedge cluster
randomized controlled trial design aiming to include over 2000 future parents from six municipalities in the
Netherlands. The intervention has a dual-track approach, focusing on both the uptake of PCC among future parents
and the provision of PCC by healthcare providers. The PCC-approach consists of 1) a social marketing strategy
directed towards prospective parent(s) and 2) a local care pathway to improve interdisciplinary collaboration. Data
will be collected before and after the introduction of the intervention through questionnaires and medical records
in each of the participating municipalities. The primary outcome of this study is change in lifestyle behaviours (e.g.
folic acid use, smoking and alcohol use). Secondary outcomes are pregnancy outcomes (e.g. miscarriage, preterm
birth, gestational diabetes) and the uptake of PCC. Moreover, a process evaluation will be performed, providing
information on the efficacy, feasibility, barriers and facilitators regarding the implementation of the intervention.
Discussion: The APROPOS-II study introduces a locally tailored PCC-approach in six municipalities in the
Netherlands that will contribute to the body of evidence regarding the effectiveness of PCC and its
implementation. If this intervention has a positive effect on lifestyle behaviour changes, leading to improved
pregnancy outcomes and the future health of prospective parents and their offspring, it could subsequently be
upscaled to (inter)national implementation.
Trial registration: Dutch Trial register: NL7784 (Registered June 6th, 2019).
Keywords: Preconception care, Pregnancy planning, Maternity care, Behavioural change, Health behaviour,
Pregnancy planning, Health promotion, Healthcare providers
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Background
Despite major advances in clinical research and medical
technology, the prevalence of adverse maternal and
neonatal health outcomes, such as pre-eclampsia and
preterm birth, have only moderately decreased over the
past decade [1]. As the first few weeks of pregnancy are
crucial for gametogenesis, organogenesis and placental
development, there is growing evidence that exposure to
unhealthy lifestyle behaviours before or during preg-
nancy (such as alcohol consumption, smoking, physical
inactivity, excessive weight gain, obesity and poor nutri-
tion), often affect the future health of mothers, their off-
spring and future generations [2–4]. In the Netherlands,
85% of all pregnancies are planned pregnancies [5].
However, planning a pregnancy is not always accompan-
ied by appropriate preparation for pregnancy. As such,
only half of all pregnant women use folic acid in the cor-
rect dose for the correct amount of time and more than
60% of all women with a wish to conceive still use alco-
hol [5]. A recent study among future fathers showed that
the majority of them took no action to improve their
lifestyle behaviours before conception [6]. Therefore, it
is important to improve awareness among prospective
parents regarding (unhealthy) preconceptional lifestyle
behaviours and its effect on reproductive outcomes and
to encourage prospective parents to actively prepare for
pregnancy.
One way to actively prepare for pregnancy is by using
preconception care (PCC). PCC is defined as “a set of
interventions that aim to identify and modify medical,
behavioural and social risks to a woman’s health or preg-
nancy outcome through prevention and management”
[7]. Despite a growing body of evidence showing that
PCC can increase the health and well-being of prospective
parents, the uptake of PCC-consults remains remarkably
low [8]. Even more cause for concern is that vulnerable
women, who often have multiple unhealthy lifestyle behav-
iours, are specifically hard to reach [9]. Previous studies have
shown that barriers for the use of PCC are determined by
the presence of preconditions, women’s beliefs, perceptions
and experiences, given the limited availability and the inad-
equate infrastructure in which PCC is provided [10, 11]. Pre-
viously developed PCC-interventions tend to be clinical and
focus on individual-level behaviour change (i.e. counselling
women not to engage in risky behaviours) rather than exam-
ining social, structural and environmental factors that shape
preconception health [12].
A previous feasibility study performed by our group
(APROPOS) in one municipality of the Netherlands showed
that a locally tailored PCC-approach has the potential to
positively affect preconceptional lifestyle behaviours and in-
creases the use of PCC among prospective parents [13].
After being exposed to the intervention, women were
more likely to make at least one preconceptional
lifestyle behaviour change compared to women who
were not exposed to the intervention (adjusted OR
1.56 (95%CI 1.02–2.39)) [13]. However, before this
locally tailored intervention can be implemented on
an (inter)national level, the feasibility and effectiveness
of this intervention needs to be analysed in a larger-
scale implementation study. Therefore, we designed a
second study (APROPOS-II) with implementation in
more municipalities, a larger group of respondents,
randomization, and assessment of a more comprehen-
sive set of (clinical) outcomes.
Aims and objectives
The aim of this study is to assess the effectiveness and the
implementation process of a local PCC-approach (i.e. the
intervention) on preconceptional lifestyle behaviours, health
outcomes and the reach of PCC among prospective parents
and healthcare providers. Therefore, we have specified the
following objectives:
 To determine the effect of the intervention on
preconceptional lifestyle behaviours (e.g. smoking,
alcohol use, folic acid use, physical activity) and
other risk factors (e.g. body mass index,
psychological distress, chronic illness) among
women who recently conceived;
 to assess the effect of the intervention on the reach
of prospective parents regarding PCC, the uptake of
PCC and pregnancy preparation;
 to evaluate the implementation process in order to
gain information on the feasibility, barriers and
facilitators for the implementation of the local PCC-
approach;
 to evaluate the sustainability of the intervention,
with a specific focus on the diversity within and
between the participating municipalities.
Methods / design
Study design
The APROPOS-II study uses a hybrid effectiveness-
implementation design [14, 15]. In a stepped-wedge
cluster-randomized controlled trial (RCT) we will imple-
ment and evaluate the effectiveness of the intervention.
Randomization occurs at a cluster-level instead of an
individual-level because the intervention has a community-
approach in which the entire target population will be
exposed to the intervention. All participating municipalities
start with a control-phase, which will last 6–16months
depending on randomization order. The total duration of
the study is 30months (Fig. 1). The RE-AIM (reach, effect-
iveness, adoption, implementation, maintenance) frame-
work will be used to evaluate the intervention and the
implementation strategy [16].
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Study population and setting
The study will be conducted in six municipalities dis-
tributed throughout the Netherlands (i.e. Amersfoort,
Barneveld, Deventer, Tilburg, Utrecht and Zoetermeer). In
total, ten community midwifery practices in these munici-
palities participate in the study. Municipalities were
selected for diversity regarding their size (varying from 57,
000–211,000 inhabitants), population, health challenges
and organization of care. All women above the age of 18
years who adequately master the Dutch, English, Polish or
Turkish language are eligible to participate in this study.
Men are recruited through their participating partners.
Our intervention targets all men and women in their
reproductive life span. In all six participating municipal-
ities together, this is approximately 270,000 people [17].
Figure 2 shows how the number of people in the target
population results in the total number of respondents.
Intervention
The intervention used in this study is a PCC-approach
tailored to the needs of prospective parent(s) and health-
care providers in a local setting. This intervention has
been developed based on pre-implementation research
in the APROPOS feasibility study [13]. The intervention
Fig. 1 Timeline of the APROPOS-II study. All participating municipalities start with a control-phase, which will last 6–16months depending on
randomization order. After the control phase, the intervention will be implemented stepwise in every municipality
Fig. 2 Overview of the studypopulation of the APROPOS-II study. This figure shows how the number of people in the target population results in
the total number of respondents for the APROPOS-II study. The intervention targets all men and women in their reproductive life span within a
municipality. We aim to include 2267 women in the study
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has a dual-track approach based on both the uptake and
the provision of PCC.
1) Uptake of PCC: To improve preconceptional
lifestyle behaviours and the uptake of PCC, a social
marketing strategy, directed towards prospective
parent(s), will be distributed in each participating
municipality. This online and offline social
marketing strategy aims to trigger prospective
parents to actively prepare for pregnancy by
directing them towards reliable PCC-information
and promoting individual PCC-consults.
2) Provision of PCC: To improve interdisciplinary
collaboration among healthcare providers, a local
care pathway will be developed and implemented in
each participating municipality, including
interdisciplinary arrangements for collaboration and
referral between primary, secondary and tertiary
care. Moreover, a working conference will be held
among local healthcare providers of
multidisciplinary backgrounds and a stakeholder
coalition will be formed.
Implementation of the intervention
Concerning the uptake of PCC, the social marketing
strategy has been developed by a professional and expe-
rienced marketing agency. A social marketing strategy
uses commercial marketing technologies to design pro-
grams that can influence the behaviour of the target
audience in order to improve personal welfare and that
of society [18]. The theoretical foundation for this social
marketing strategy is based on research regarding the
target population’s perception from biological-, emo-
tional-, social- and cultural point of views and resulted
in the concept of “Woke Women®”, with the single-
minded proposition: “Wake up smart (future) Mama!
Let’s make your baby strong”. The social marketing
strategy uses different channels of communication, e.g.
online marketing, traditional offline marketing channels,
word-of-mouth marketing and social networks will be
addressed to start a social movement. Its purpose is to
use existing social networks to encourage women to mo-
tivate each other towards healthy behaviour. Examples
of materials used in the social marketing strategy are
shown in Fig. 3 and more information about the social
marketing strategy can be found on www.wokewomen.nl
(in Dutch).
Regarding the provision of PCC, the working conference
for the healthcare providers aims to educate them on pre-
conceptional health and risk factors using the national
Preconception Indication List (PIL), emphasizes the im-
portance of facilitating PCC and is used to conduct a
region-specific bottleneck analysis [5] [19]. Subsequently,
a multidisciplinary group of healthcare providers will form
a local stakeholder coalition. With the input of these stake-
holders, the intervention will be tailored to the participating
municipality prior to implementation by adapting the dis-
semination locations, the design of the intervention and the
essential elements included in the intervention.
Clinical parameters and outcomes
Study parameters will be assessed by a questionnaire dis-
tributed among prospective parent(s) by the participating
community midwifery practices in the first trimester of
pregnancy. The questionnaire is based on validated ques-
tionnaires such as WHO - Quality of life questionnaire,
the London Measure of Unplanned Pregnancy (LMUP), a
validated preconception tool (www.zwangerwijzer.nl) and
the APROPOS feasibility study [20, 21]. The questionnaire
contains five sections: pregnancy planning, pregnancy
preparation, healthy lifestyle behaviours and risk factors,
personal situation and the prospective father. There are two
versions of the questionnaire, one pre-implementation and
one post-implementation. The post-implementation ques-
tionnaire contains additional evaluation questions about
participant’s experiences with the social marketing strategy.
Fig. 3 Sociale marketing strategy Woke Women®. Examples of the
promotional material (visuals) of the social marketing strategy Woke
Women® which has been specifically developed for this study
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An overview of all the variables in the questionnaire is
shown in Table 1. The questionnaire is available in Dutch,
English, Polish and Turkish; languages that are mastered by
the majority of the inhabitants of the participating munici-
palities. The questionnaire for prospective fathers is shorter
compared to the questionnaire for pregnant women and
solely focusses on lifestyle behaviours and health beliefs.
The primary outcome of this study is change in life-
style behaviours. This is a composite outcome of four
modifiable lifestyle behaviours (healthier diet, folic acid
use, quit drinking and quit smoking during the precon-
ception period), expressed as the number of women who
preconceptionally change at least one of these lifestyle
behaviours from inadequate to adequate. The definitions
of healthy lifestyle behaviour are based on Dutch guide-
lines and are provided in Table 1.
Secondary outcomes are pregnancy outcomes (e.g.
miscarriage, preterm birth, gestational diabetes) and the
uptake of PCC. The definitions of these pregnancy out-
comes are given in Table 1 and will be collected from
the participants’ medical records after obtaining add-
itional informed consent. The uptake of PCC will be
measured through a section in the questionnaire and by
the records of the midwifery practices on PCC-consults.
Implementation parameters and outcomes
The RE-AIM framework will be used to evaluate the
intervention and the implementation strategy. This
framework is a practical way of evaluating health inter-
ventions and has previously been used in studies focused
on changing individual behaviours [16]. Regarding pa-
tient implementation outcomes, the respondents’ satis-
faction towards the PCC-consults will be assessed by
elements of the validated ReproQ, which is based on the
WHO-concept responsiveness and has been incorpo-
rated in our questionnaire [37, 38].
Healthcare providers’ implementation outcomes will be
measured by a 23-item validated NoMAD (Normalisation
MeAsure Development) questionnaire. The NoMAD
questionnaire will be used to describe the health care pro-
viders’ views on how the intervention impacts their work
and their expectations about whether the intervention
could become a routine part of their work [39]. The
healthcare providers will receive this questionnaire 3
months before the start of the intervention-phase and a
follow-up questionnaire 6 months later. Barriers and facili-
tators regarding the implementation of the PCC-approach
will be collected among healthcare providers and classified
using the Flottorp et al. - checklist [40].
Finally, the feasibility of the implementation of the
local care pathways will be evaluated among healthcare
providers. We will measure to what degree the local care
pathway was distributed amongst the healthcare pro-
viders and how healthcare providers experienced the
convenience of this tool. In each municipality, focus
groups with the local stakeholder coalition will be held 9
months after the start of the intervention and will be
analysed using thematic analysis to identify key issues
and themes. In these focus groups, information will be
gathered on how the intervention complies with the het-
erogeneity of local settings, since differences in healthcare
networks, logistics and practical issues call for tailored
approaches.
Sample size calculation
Based on the results from the APROPOS feasibility
study, we anticipate on an odds ratio of 1.5 in lifestyle
behaviour change during the preconception period (pri-
mary outcome). Based on the sample size estimation
method of Hemming and Taljaard, with an alpha of
0.05, power of 80% and a low intraclass correlation Coef-
ficient of 0.02, the sample size was calculated to be 363
participants per unit with 6 units (=municipalities; 2167
in total, 23 participants per month per municipality)
[41]. Considering our inclusion criteria, almost all
women who have their intake visit during the study
period are eligible respondents. Based on previous ex-
perience, we expect that 50–60% of these women will fill
out the questionnaire.
Statistical analysis
Statistical analysis will be performed using multilevel
logistic regression analysis to take into account the clus-
tering of respondents within municipalities. Data will be
analysed anonymously on two levels; the respondents’
level (before and after the intervention) and the munici-
pal level (differences between municipalities). Baseline
characteristics will be compared between the pre- and
post-intervention group and compared in a baseline
table. Chi-square analysis and ANCOVA will be used to
study the effects of the intervention on the adverse preg-
nancy outcomes. Adjusted odds ratios will be calculated
taking into account the potential confounders: age, edu-
cational level and parity. P-values < 0.05 are considered
statistically significant.
Discussion
The APROPOS-II study introduces a locally tailored PCC-
approach in six municipalities in the Netherlands, that will
contribute to current knowledge regarding the implemen-
tation and the effectiveness of PCC. Until now there is
little data from randomized clinical trials that prove the
effectiveness of PCC on maternal and perinatal health out-
comes [3, 42, 43]. This evidence is necessary to substantiate
the urgency to invest in a comprehensive (inter)national
PCC-program. The presented intervention serves the differ-
ent needs of prospective parents by providing both separate
preconception health information and PCC-consultation.
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Table 1 Definition of primary and secondary outcomes of the APROPOS-II study
Variable Definition*
Pregnancy preparation Level of pregnancy planning London Measure of Unplanned Pregnancies (LMUP) [21]
PCC health seeking behaviour Acquired PCC-information through the internet, books,
journals, folders or family & friends.
PCC-consult A consultation provided by a healthcare provider.
Modifying lifestyle behaviours & risk factors Fruit intake ≥ 2 pieces of fruit a day [22]
Vegetable intake ≥ 200 g of vegetables a day [22]
Caffeine intake ≤ 1 caffeine-containing beverage [22]
Exercising ≥ 150min per week moderate or heavy intensive
exercise, spread over various days [23]
Smoking No smoking [5, 24]
Alcohol intake No alcohol intake [5, 24]
Folic acid usage ≥400 microgram per day, 4 weeks preconceptionally
until 10 weeks gestation [5, 24]
Medication usage Risk-free medication [5]
Psychological distress A stable emotional state [5]
Vaccination status Vaccination status should be discussed with special
attention to rubella, measles and whooping cough.
Based on individual assessment of antibody titres;
(re)vaccinations can be considered [24]
Working conditions Avoid contact with harmful working conditions [5]
Prenatal outcomes Miscarriage Loss of pregnancy before 24 weeks [25].
Gestational Diabetes (GDM) Diagnosed by a 75-g oral glucose tolerance test (OGTT)
as the presence of either a fasting glucose level of
≥7.0 mmol/L (126mg/dl) or a glucose level of
≥7.8 mmol/L (140mg/dl) after two hours [26, 27]
Pregnancy-induced hypertension (PIH) New onset of hypertension (≥ 140mmHg systolic and/or
≥ 90 mmHg diastolic blood pressure) after 20 weeks
gestation measured on at least two occasions four hours
apart [28, 29]
Pre-eclampsia (PE) PIH accompanied by proteinuria (≥300mg in 24 h)
[29, 30]
Spontaneous preterm birth Delivery with spontaneous onset before 37 weeks of
gestation [31].
Referral to secondary care If complications occur or threaten to occur, the midwife
will refer the woman to the obstetrician who will take
over the care for as long as deemed necessary [32].
Birth outcomes Mode of delivery Spontaneous vaginal delivery, assisted vaginal delivery,
or caesarean section [33].
Referral to secondary care If complications occur or threaten to occur, the midwife
will refer the woman to the obstetrician who will take
over the care for as long as deemed necessary [32].
Neonatal outcomes Small for gestational age (SGA) Birth weight < 10th percentile, based on Dutch national
reference curves adjusted for parity, gestational age, sex
and ethnicity [34].
Congenital anomalies Structural-morphological, functional and/or biochemical-
molecular defects
present at birth [35].
APGAR- score A score is a sum of the values assigned to the infant at 1
and 5 min of life, with a score of 7 or more indicating
that the baby is in good to excellent condition [36].
* Definitions are based on Dutch standards
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This supports the view that most prospective parents will
benefit from evidence-based information to prepare them-
selves for pregnancy, while not every prospective parent will
attend a PCC-consult.
Despite the low uptake of PCC-consults, the majority of
prospective parents use the internet as their primary
source of information regarding preconception health
[11]. Women appreciate anonymity and self-management
of online information in the privacy of their own home
[11, 44]. The aim of the social marketing strategy in this
intervention is to trigger women to actively prepare for
their pregnancy by guiding them towards a website (www.
wokewomen.nl) with practical and evidence-based infor-
mation to help them improve their preconceptional health
status. In addition, we encourage these women when there
is a need for extra information to visit a healthcare pro-
vider for a PCC-consult.
Previous literature on social marketing strategies showed
that it has the potential to improve diet, increase exercise
and reduce substances-use like tobacco, and alcohol [18].
Creating a social movement could raise awareness on the
importance of PCC and could cause a supportive social en-
vironment for preconception health. In addition, research
shows that healthcare collaborations in health promotion
can result in effective and sustainable benefits for those
involved [45]. When effectively facilitated, healthcare col-
laborations can enable fundamental improvements to com-
munity development and health promotion.
Strengths of this stepped-wedge cluster RCT are the
diversity of the population in the participating munici-
palities and the tailored intervention that complies with
the heterogeneity of local settings. Moreover, the de-
tailed questionnaire investigating respondents’ lifestyle
behaviours, health beliefs and the extent of planning of
the current pregnancy based on validated questionnaires
can be considered a strength of this study. In addition,
the innovative social marketing strategy, the extensive
process evaluation and the involvement of the prospect-
ive father highlight different and often neglected aspects
of PCC-research.
A potential limitation of this study is the occurrence of
selection bias, as participants who have actively prepared
for their pregnancy are probably more eager to share their
experience. However, in our previous feasibility study, re-
sponse rates were high and the population characteristics
were similar before and after introduction of the interven-
tion [13]. Another limitation is the selection strategy, as
the respondents of this study are pregnant while the inter-
ventions focusses on the preconceptional period. Previous
studies already showed that prospective parents are very
difficult to identify and recruit, therefore almost all PCC
related studies obtain information retrospectively [46]. Fi-
nally, active participation of the healthcare providers is cru-
cial to make the local PCC-pathway a success. Fortunately,
the healthcare providers involved in the local PCC-pathway
are driven to improve the awareness of PCC in their muni-
cipality and will be equipped to provide adequate PCC. All
community midwifery practices have already been recruited
and municipal policy makers are involved throughout the
entire project.
With this study, we expect to effectively implement
and evaluate a locally tailored PCC-approach. If this
intervention will show to improve lifestyle behaviours,
leading to improved pregnancy outcomes and future
health of prospective parents and their offspring, it may
be upscaled to (inter)national implementation.
Abbreviations
LMUP: London Measure of Unplanned Pregnancy; NoMAD: Normalisation
MeAsure Development; PCC: Preconception Care; RCT: Randomized
Controlled Trial; RE-AIM: Reach, Effectiveness, Adoption, Implementation,
Maintenance; WHO: World Health Organisation
Acknowledgements
The authors gratefully acknowledge dr. Henk F. van Stel, who unfortunately
passed away in 2018, for his invaluable contribution to the rationale and
design of this study.
Authors’ contributions
AF and MP are responsible for the rationale and design of the study and
acquired the funding. MPHK contributes expertise in the statistical analysis
and EI in the process evaluation. The APROPOS-II project commission
members (KLHvA, RWAdB, DJdS, BCV and EHvV) contributed to the design of
the study and provided input for the practical implementation of the study.
VYFM is the executive researcher, supervised by MPHK, AF, and MP. VYFM,
MPHK and MP prepared the first draft of the protocol. All authors have read
and approved the final manuscript.
Funding
This work was supported by the Netherlands Organization for Health
Research and Development (ZonMw) under grant number 50–54300–98-230.
The funder had no role in the design of the study.
Availability of data and materials
Not applicable
Ethics approval and consent to participate
This study has been approved by the Medical Ethical Review Board (MEC-
2019-0278) of the Erasmus MC, University Medical Centre Rotterdam and all




The authors declare that they have no competing interest.
Author details
1Department of Obstetrics and Gynaecology, University Medical Centre
Rotterdam, RotterdamDoctor Molewaterplein 40, 3015, GD, the Netherlands.
2Department of Internal Medicine - Nursing Science, Erasmus MC, University
Medical Centre Rotterdam, RotterdamDoctor Molewaterplein 40, 3015, GD,
the Netherlands. 3HELLP foundation, ZwollePostbus 40126, 8004, DC, the
Netherlands. 4Department of Obstetrics, Diakonessenhuis hospital,
UtrechtBosboomstraat 1, 3582, KE, the Netherlands. 5MediClara Projects,
BaambruggePrinses Beatrixstraat 7, 1396, KD, the Netherlands. 6Geboorte
Concortium Midden Nederland (GCMN), UtrechtOudlaan 4, 3515, GA, the
Netherlands. 7Dutch Genetic Alliance, VSOP, UtrechtKoninginnelaan 23, 3762
DA Soestthe Netherlands. 8Research agency Care2Research,
AmsterdamMattenbiesstraat 133, 1087, GC, the Netherlands.
Maas et al. BMC Public Health          (2020) 20:235 Page 7 of 9
Received: 28 January 2020 Accepted: 6 February 2020
References
1. Atrash HK, Johnson K, Adams M, Cordero JF, Howse J. Preconception care
for improving perinatal outcomes: the time to act. Matern Child Health J.
2006;10(5 Suppl):S3–11.
2. de Weerd S, Steegers EA. The past and present practices and continuing
controversies of preconception care. Community Genet. 2002;5(1):50–60.
3. Temel S, van Voorst SF, Jack BW, Denktaş S, Steegers EAP. Evidence-based
preconceptional lifestyle interventions. Epidemiol Rev. 2013;36(1):19–30.
4. Louis GMB, Cooney MA, Lynch CD, Handal A. Periconception window:
advising the pregnancy-planning couple. Fertil Steril. 2008;89(2):e119–e21.
5. College Perinatale Zorg (Perinatal Care College). Preconceptie Indicatie Lijst
(preconception indication list). 2018. https://www.kennisnetgeboortezorg.nl/
wp-content/uploads/2019/06/Preconceptie_Indicatie_Lijst_PIL_.pdf.
Accessed 11 June 2019.
6. Shawe J, Patel D, Joy M, Howden B, Barrett G, Stephenson J. Preparation for
fatherhood: a survey of men’s preconception health knowledge and
behaviour in England. PLoS One. 2019;14(3):e0213897.
7. Johnson K, Posner SF, Biermann J, Cordero JF, Atrash HK, Parker CS, et al.
Recommendations to Improve Preconception Health and Health
Care—United States: Report of the CDC/ATSDR Preconception Care Work
Group and the Select Panel on Preconception Care. MMWR Recomm Rep.
2006;55(6):1-CE-4.
8. World health O. meeting to develop a global consensus on preconception
care to reduce maternal and childhood mortality and morbidity: World
Health Organization headquarters, Geneva, 6–7 February 2012: Meeting
report 2013.
9. M'Hamdi HI, van Voorst SF, Pinxten W, Hilhorst MT, Steegers EA. Barriers in
the uptake and delivery of preconception care: exploring the views of care
providers. Matern Child Health J. 2017;21(1):21–8.
10. Poels M, Koster MPH, Boeije HR, Franx A, van Stel HF. Why do women not
use preconception care? A systematic review on barriers and facilitators.
Obstet Gynecol Surv. 2016;71(10):603–12.
11. Poels M, Koster MPH, Franx A, van Stel HF. Parental perspectives on the
awareness and delivery of preconception care. BMC Pregnancy Childbirth.
2017;17(1):324.
12. Hemsing N, Greaves L, Poole N. Preconception health care interventions: a
scoping review. Sex Reprod Healthc. 2017;14:24–32.
13. Poels M, van Stel HF, Franx A, Koster MPH. The effect of a local promotional
campaign on preconceptional lifestyle changes and the use of
preconception care. Eur J Contracept Reprod Health Care. 2018;23(1):38–44.
14. Curran GM, Bauer M, Mittman B, Pyne JM, Stetler C. Effectiveness-
implementation hybrid designs: combining elements of clinical
effectiveness and implementation research to enhance public health
impact. Med Care. 2012;50(3):217.
15. Hemming K, Haines TP, Chilton PJ, Girling AJ, Lilford RJ. The stepped wedge cluster
randomised trial: rationale, design, analysis, and reporting. Bmj. 2015;350:h391.
16. King DK, Glasgow RE, Leeman-Castillo B. Reaiming RE-AIM: using the model
to plan, implement, and evaluate the effects of environmental change
approaches to enhancing population health. Am J Public Health. 2010;
100(11):2076–84.
17. Centraal Bureau voor de Statistiek (Central Bureau of Statistics). Kerncijfers
Wijken en Buurten (Key figures Districs and Neighborhoods) 2018. [internet]
URL: https://www.waarstaatjegemeente.nl [accessed on 06-11-2019].
18. Gordon R, McDermott L, Stead M, Angus K. The effectiveness of social
marketing interventions for health improvement: what's the evidence?
Public Health. 2006;120(12):1133–9.
19. Poels M, Koster MP, Franx A, van Stel HF. Healthcare providers' views on the
delivery of preconception care in a local community setting in the
Netherlands. BMC Health Serv Res. 2017;17(1):92.
20. Group TW. The World Health Organization quality of life assessment
(WHOQOL): development and general psychometric properties. Soc Sci
Med. 1998;46(12):1569–85.
21. Barrett G, Smith SC, Wellings K. Conceptualisation, development, and
evaluation of a measure of unplanned pregnancy. J Epidemiol Community
Health. 2004;58(5):426–33.
22. The Netherlands Nutrition Centre (het voedingscentrum). 2015.
Zwangerschap (Pregnancy) [internet] URL: https://www.voedingscentrum.nl/
professionals/kindervoeding-0-4-jaar/zwangerschap.aspx [].
23. Gezondheidsraad (Health Council). Bewegingsrichtlijn (Movement Directive)
2017. 2017;2017/08. .
24. Shawe J, Delbaere I, Ekstrand M, Hegaard HK, Larsson M, Mastroiacovo P,
et al. Preconception care policy, guidelines, recommendations and services
across six European countries: Belgium (Flanders), Denmark, Italy, the
Netherlands, Sweden and the United Kingdom. Eur J Contracept Reprod
Health Care. 2015;20(2):77–87.
25. Royal College of O, Gynaecologists. The management of early pregnancy
loss. Green top Guideline. 2006(25).
26. Alberti KGMM, Zimmet PZ. Definition, diagnosis and classification of
diabetes mellitus and its complications. Part 1: diagnosis and classification
of diabetes mellitus. Provisional report of a WHO consultation. Diabet Med.
1998;15(7):539–53.
27. NVOG: Dutch Society of Obstetrics and Gynecology. Diabetes mellitus en
zwangerschap. (Diabetes mellitus and pregnancy) 2010;Version 2.0.
[internet] URL: https://www.nvog.nl/wp-content/uploads/2018/02/Diabetes-
mellitus-en-zwangerschap-2.0-04-06-2010.pdf [accessed 2019-07-12].
28. Brown MA, Lindheimer MD, de Swiet M, Van Assche A, Moutquin JM. The
classification and diagnosis of the hypertensive disorders of pregnancy:
statement from the International Society for the Study of Hypertension in
Pregnancy (ISSHP). Hypertens Pregnancy. 2001;20(1):IX-XIV.
29. NVOG: Dutch Society of Obstetrics and Gynecology. Chronische Hypertensie




30. Uzan J, Carbonnel M, Piconne O, Asmar R, Ayoubi JM. Pre-eclampsia:
pathophysiology, diagnosis, and management. Vasc Health Risk Manag.
2011;7:467–74.
31. Lumley J. Defining the problem: the epidemiology of preterm birth. BJOG
Int J Obstet Gynaecol. 2003;110:3–7.
32. Amelink-Verburg MP, Buitendijk SE. Pregnancy and labour in the Dutch
maternity care system: what is normal? The role division between midwives
and obstetricians. J Midwifery Women’s Health. 2010;55(3):216–25.
33. Wu J, Viguera A, Riley L, Cohen L, Ecker J. Mood disturbance in pregnancy
and the mode of delivery. Am J Obstet Gynecol. 2002;187(4):864–7.
34. Visser GHA, Eilers PHC, Elferink-Stinkens PM, Merkus HMWM, Wit JM. New
Dutch reference curves for birthweight by gestational age. Early Hum Dev.
2009;85(12):737–44.
35. Czeizel AE, Intody Z, Modell B. What proportion of congenital abnormalities
can be prevented? Bmj. 1993;306(6876):499–503.
36. Leuthner SR, Das UG. Low Apgar scores and the definition of birth asphyxia.
Pediatr Clin N Am. 2004;51(3):737–45.
37. Scheerhagen M, Van Stel HF, Birnie E, Franx A, Bonsel GJ. Measuring client
experiences in maternity care under change: development of a
questionnaire based on the WHO responsiveness model. PLoS One. 2015;
10(2):e0117031.
38. Valentine NB, de Silva A, Kawabata K, Darby C, Murray CJL, Evans DB. Health
system responsiveness: concepts, domains and operationalization. In: Health
systems performance assessment: debates, methods and empiricism.
Geneva: World Health Organization; 2003. p. 573–96.
39. May CR, Mair FS, Dowrick CF, Finch TL. Process evaluation for complex
interventions in primary care: understanding trials using the normalization
process model. BMC Fam Pract. 2007;8(1):42.
40. Flottorp SA, Oxman AD, Krause J, Musila NR, Wensing M, Godycki-Cwirko M,
et al. A checklist for identifying determinants of practice: a systematic
review and synthesis of frameworks and taxonomies of factors that prevent
or enable improvements in healthcare professional practice. Implement Sci.
2013;8:35.
41. Hemming K, Taljaard M. Sample size calculations for stepped wedge and
cluster randomised trials: a unified approach. J Clin Epidemiol. 2016;69:137–46.
42. Hussein N, Kai J, Qureshi N. The effects of preconception interventions on
improving reproductive health and pregnancy outcomes in primary care: a
systematic review. Eur J Gen Pract. 2016;22(1):42–52.
43. Whitworth M, Dowswell T. Routine pre-pregnancy health promotion for
improving pregnancy outcomes. Cochrane Database Syst Rev. 2009;4.
44. van Dijk MR, Oostingh EC, Koster MPH, Willemsen SP, Laven JSE,
Steegers-Theunissen RPM. The use of the mHealth program smarter
pregnancy in preconception care: rationale, study design and data
collection of a randomized controlled trial. BMC pregnancy childbirth.
2017;17(1):46.
Maas et al. BMC Public Health          (2020) 20:235 Page 8 of 9
45. Estacio EV, Oliver M, Downing B, Kurth J, Protheroe J. Effective partnership
in community-based health promotion: Lessons from the health literacy
partnership. Int J Environ Res Public Health. 2017;14(12):1550.
46. Gollenberg AL, Mumford SL, Cooney MA, Sundaram R, Louis GM. Validity of
retrospectively reported behaviors during the periconception window. J
Reprod Med. 2011;56(3–4):130–7.
Publisher’s Note
Springer Nature remains neutral with regard to jurisdictional claims in
published maps and institutional affiliations.
Maas et al. BMC Public Health          (2020) 20:235 Page 9 of 9
